Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projekte/494-a-multicenter-phase-iii-randomized-study-with-second-line-chemotherapy-plus-or-minus-bevacizumab-in-patients-with-plati-num-sensitive-epithelial-ovarian-cancer-recurrence-after-a-bevacizumabchemotherapy-first-line/autoren